P208 A pilot study of low-dose capecitabine plus trastuzumab as first-line treatment for patients older than 75 years with HER2-positive advanced gastric cancer

✍ Scribed by Sym, S.J.; Kim, Y.S.; Park, I.; Ahn, H.K.; Hong, J.; Park, J.; Cho, E.K.; Lee, J.H.; Lee, W.K.; Chung, M.; Kim, H.-S.; Shin, D.B.

• Book ID: 125824432
• Publisher: Elsevier Science
• Year: 2014
• Tongue: English
• Weight: 35 KB
• Volume: 50
• Category: Article
• ISSN: 0959-8049
• DOI: 10.1016/j.ejca.2014.03.252